These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36937890)

  • 21. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
    He X; Liu J; Long G; Xia XH; Liu M
    Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sinapic Acid Ameliorates Acetic Acid-Induced Ulcerative Colitis in Rats by Suppressing Inflammation, Oxidative Stress, and Apoptosis.
    Shahid M; Raish M; Ahmad A; Bin Jardan YA; Ansari MA; Ahad A; Alkharfy KM; Alaofi AL; Al-Jenoobi FI
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807383
    [No Abstract]   [Full Text] [Related]  

  • 23. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; Wang Y; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006618. PubMed ID: 25162749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients.
    Wang Y; Ouyang Q;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1450-5. PubMed ID: 17716349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polysaccharides from natural resources exhibit great potential in the treatment of ulcerative colitis: A review.
    Niu W; Chen X; Xu R; Dong H; Yang F; Wang Y; Zhang Z; Ju J
    Carbohydr Polym; 2021 Feb; 254():117189. PubMed ID: 33357839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis.
    Zhou J; Liu J; Gao Y; Shen L; Li S; Chen S
    Front Pharmacol; 2021; 12():707776. PubMed ID: 34305614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for the management of abdominal pain in ulcerative colitis.
    Sinopoulou V; Gordon M; Dovey TM; Akobeng AK
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013589. PubMed ID: 34291816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Licoflavone B, an isoprene flavonoid derived from licorice residue, relieves dextran sodium sulfate-induced ulcerative colitis by rebuilding the gut barrier and regulating intestinal microflora.
    Zhang J; Xu X; Li N; Cao L; Sun Y; Wang J; He S; Si J; Qing D
    Eur J Pharmacol; 2022 Feb; 916():174730. PubMed ID: 34968462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics for maintenance of remission in ulcerative colitis.
    Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis.
    Wang Y; Tang Q; Duan P; Yang L
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):476-482. PubMed ID: 30111198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function of intestinal barrier protected by regulating the miR-199a-3p in ulcerative colitis: Modulation of IL-23/IL-17A axis.
    Zhang H; Zhang F; Li W
    Fundam Clin Pharmacol; 2021 Oct; 35(5):852-860. PubMed ID: 33475196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential activity of Traditional Chinese Medicine against Ulcerative colitis: A review.
    Liu Y; Li BG; Su YH; Zhao RX; Song P; Li H; Cui XH; Gao HM; Zhai RX; Fu XJ; Ren X
    J Ethnopharmacol; 2022 May; 289():115084. PubMed ID: 35134488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogel-metal-organic-framework hybrids mediated efficient oral delivery of siRNA for the treatment of ulcerative colitis.
    Gao M; Yang C; Wu C; Chen Y; Zhuang H; Wang J; Cao Z
    J Nanobiotechnology; 2022 Sep; 20(1):404. PubMed ID: 36064365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Ulcerative Effect of Curcumin-Galactomannoside Complex on Acetic Acid-Induced Experimental Model by Inhibiting Inflammation and Oxidative Stress.
    Sheethal S; Ratheesh M; Jose SP; Asha S; Krishnakumar IM; Sandya S; Girishkumar B; Grace J
    Inflammation; 2020 Aug; 43(4):1411-1422. PubMed ID: 32240451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different therapy for different types of ulcerative colitis in China.
    Jiang XL; Cui HF
    World J Gastroenterol; 2004 May; 10(10):1513-20. PubMed ID: 15133864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Murray A; Nguyen TM; Parker CE; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD000544. PubMed ID: 32856298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Japanese pediatric patient with moderately active ulcerative colitis successfully treated with ustekinumab: A case report.
    Kakiuchi T; Yoshiura M
    Medicine (Baltimore); 2022 Feb; 101(7):e28873. PubMed ID: 35363198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.